<DOC>
	<DOCNO>NCT00955409</DOCNO>
	<brief_summary>The purpose study assess long term safety , tolerability , immunogenicity ACC-001 , investigational active immunization product+ , subject mild moderate Alzheimer 's disease .</brief_summary>
	<brief_title>Long Term Extension Study Evaluating Safety , Tolerability Immunogenicity Of ACC-001 In Subjects With Mild To Moderate Alzheimer 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>QS 21</mesh_term>
	<criteria>Subjects randomize previous 3134K1200 study ( NCT00479557 ) meet inclusion/and none exclusion criterion Screening brain MRI scan consistent diagnosis AD ' MiniMental State Examination ( MMSE ) score =10 Significant Neurological Disease Alzheimer 's disease Brain MRI evidence vasogenic edema ( VE ) precede 3134K1 200 study ( NCT00479557 ) Clinically significant systemic illness</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>